Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: the Pharm-TCR randomized controlled trial protocol

被引：0
作者：
Cody Durrer
Sean McKelvey
Joel Singer
Alan M. Batterham
James D. Johnson
Jay Wortman
Jonathan P. Little
机构：
[1] University of British Columbia,School of Health and Exercise Sciences
[2] Institute for Personalized Therapeutic Nutrition,School of Population and Public Health
[3] University of British Columbia,Centre for Rehabilitation, Exercise and Sports Science
[4] Teesside University,Diabetes Research Group, Life Sciences Institute, Faculty of Medicine
[5] University of British Columbia,Faculty of Medicine
[6] University of British Columbia,undefined
来源：
Trials | / 20卷
关键词：
Diabetes; Ketogenic diet; Glucose; A1C; Diet; Nutrition; Pharmacy; Insulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 128 条
  • [1] Zimmet P(2003)The burden of type 2 diabetes: are we doing enough? Diabetes Metab 29 6S9-618
  • [2] Lipscombe L(2018)Pharmacologic glycemic management of type 2 diabetes in adults Can J Diabetes 42 S88-103
  • [3] Booth G(2006)Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: response to Farooki and Schneider [15] Diabetes Care 29 1990-1991
  • [4] Butalia S(2016)Liraglutide and cardiovascular outcomes in type 2 diabetes N Engl J Med 375 311-322
  • [5] Dasgupta K(2008)Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all- cause mortality? Diabetes Care 31 1672-1678
  • [6] Eurich DT(2015)Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes N Engl J Med 373 2117-2128
  • [7] Goldenberg R(2014)Incidence of remission in adults with type 2 diabetes: the diabetes & aging study Diabetes Care 37 3188-3195
  • [8] Bowker SL(2001)Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials JAMA 286 1218-1227
  • [9] Majumdar SR(1999)Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (ukpds 49) JAMA 281 2005-2012
  • [10] Veugelers P(2018)Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial Lancet 391 541-551
12345678910